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ABSTRACT 
Karen P. Tosti: Substrate Oxidation and Blood Lactate Responses to Varying Exercise 
Intensities in Breast Cancer Patients and Healthy Controls 
(Under the direction of Anthony C. Hackney, Ph.D., D.Sc.) 
 
Post-treated breast cancer patients were matched with healthy women based on 
age, physical fitness level and menopausal status.  Subjects participated in low, moderate, 
and high intensity submaximal exercise sessions that corresponded with 40% VO2max, 
60% VO2max, and 70% VO2max.  Oxygen uptake and respiratory exchange ratio were 
taken during submaximal exercise sessions to determine substrate oxidation. Blood 
lactate and blood glucose were measured before and after submaximal exercise sessions.  
The breast cancer patients had a significantly (p ≤ 0.05) lower carbohydrate oxidation 
rate and higher fat oxidation rate at all exercise intensities compared to healthy women.  
The breast cancer patients had a significantly (p ≤ 0.05) lower blood lactate response to 
exercise at all intensities compared to the healthy women.  The results indicate that post-
treated breast cancer patients have augmented lipid metabolism and reduced carbohydrate 
metabolism during submaximal exercise. 
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CHAPTER I 
 
BASIS OF STUDY 
 
Introduction 
 
Over the past 35 years breast cancer has been the most prevalent type of cancer 
diagnosed in women in the United States (Jemal et al. 2009).    Although this serious 
disease is very common, mortality rates are currently decreasing and survival rates are 
increasing (Jemal et al. 2009).  The decreased mortality rate can be attributed to earlier 
detection and more aggressive treatments (Battaglini et al. 2008; Humpel & Iverson 
2005; Jones et al. 2007; Kim et al. 2009).  These efforts have resulted in there being over 
2.4 million breast cancer survivors in the United States in 2009 (White et al. 2009). 
Treatment of breast cancer is multi-faceted and varies individually based on the 
type tumor and other individual risk factors (Jones et al. 2007).  Treatment typically 
consists of removal of a tumor and adjuvant therapies such as radiation, chemotherapy, 
hormonal therapy, or any combination of these (Segal et al. 2001).  Adjuvant treatments 
for breast cancer can have many acute and long-term debilitating side effects including 
but not limited to: a decrease in energy expenditure, weight gain, fatigue, increased risk 
of cardiovascular disease, decreased cardiopulmonary function, and decreased quality of 
life (Dimeo et al. 1998; Evans et al. 2009; Kim et al. 2009; Segal et al. 2001).    However, 
recent studies have shown positive benefits of exercise training within breast cancer 
survivors.  A review of studies showed that aerobic exercise training in breast cancer 
patients during and after adjuvant therapies significantly improved aerobic capacity and 
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body composition (Kim et al. 2009).  Segal et al. (2001) noted benefits in physical 
functioning for patients undergoing self-directed or supervised exercise when compared 
to a control group of non-exercising patients.  Patients who had not received 
chemotherapy treatments also significantly improved their aerobic capacity and body 
weight after supervised exercise sessions when compared to breast cancer controls that 
had not undergone exercise training (Segal et al. 2001).  A study of post-menopausal 
breast cancer survivors involved in exercise saw a significant increase in quality of life 
compared to non-exercising patients in the control group (Courneya et al. 2003).  
Sternfeld et al. (2009) also found that physical activity, including exercise training, in 
breast cancer survivors decreases the total occurrence of mortality due to all causes 
including cancer recurrence.       
 These positive outcomes are promising and in 2003, Brown et al. (2003) 
published general guidelines for physical activity before and after cancer treatment.  The 
following year the American College of Sports Medicine (ACSM) also established 
general exercise guidelines for cancer patients in order to provide structure for training 
programs.  These guidelines however were not specific to the type or severity of cancer.  
Concurrently, the ACSM does not have a definitive “Position Statement” for exercise 
prescription in cancer patients either during or after treatment (Humpel & Iverson 2005).  
Some basic guidelines have also been established by several other organizations but there 
are no clear evidence-based recommendations for any specific cancer population 
(Humpel & Iverson 2005).  For example, a meta-analysis of studies on exercise training 
in cancer patients showed that aerobic intensities were reported anywhere from 40% of 
heart rate reserve to 90% of maximal heart rate (Humpel & Iverson 2005).  This is an 
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extremely wide variance in this exercise prescription parameter.  Exercising at the proper 
intensity is important to gain cardiovascular benefits but should be approached cautiously 
with cancer populations due to the cardiovascular complications that may occur with 
some types of treatments (Battaglini et al.2006; Gianni et al. 2008).  Therefore, it is 
important to explore and quantify the physiological differences (i.e., cardiovascular, 
metabolic) between exercising at different intensities in cancer patients in comparison to 
normal “healthy” controls.  This information can contribute to the literature so that 
accurate guidelines and recommendations for exercise prescription in cancer patients can 
be devised.   
Researchers have extensively explored substrate oxidation levels in normal 
healthy individuals exercising at varying intensities.  There have been only a few studies, 
however, looking at substrate oxidation issues, specifically carbohydrate metabolism, in 
cancer patients.  One such study showed that diabetes or glucose intolerance was more 
frequent in cancer populations when compared to healthy controls (Glicksman & Rawson 
1956).  Another study, however, showed that fasting values of blood glucose and plasma 
free fatty acids were similar in cancer patients and normal controls (Edmonson 1966).  
Decreased glucose tolerance was noted in cancer patients compared to the normal 
controls at rest, which could potentially be the result of increased free fatty acid 
utilization (Edmonson 1966).  A greater incidence of hyperglycemia has also been shown 
in cancer patients at the time of diagnosis, however it was not determined as to whether 
this was an effect of the cancer or had been established before developing cancer 
(Glicksman & Rawson 1956).  A recent study has also found that insulin resistance and 
high fasting levels of insulin are also associated with breast cancer (Larsson et al. 2007).  
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These studies suggest that there seems to be a strong relationship between altered 
carbohydrate metabolism and breast cancer disease.  However, most of these studies were 
performed in a resting state and not in response to exercise and also at the time of 
diagnosis rather than post-treatment.   
Very few studies have looked at blood lactate and blood glucose as markers of 
carbohydrate metabolism in exercising cancer survivors.   Dimeo et al. (1998) noted that 
exercising blood lactate levels significantly decreased after a 6 week training program.  
Regrettably, this study did not compare blood lactate levels with normal healthy controls.  
A more recent study looking at blood lactate levels as an indicator of intensity during 
exercise showed that post-treated breast cancer patients had significantly lower lactate 
levels during high intensity (70% VO2max) exercise when compared to healthy matched 
controls (Evans et al. 2009).  These results were quite surprising and unexpected.  It has 
been well established that exercising at a higher intensity causes greater reliance on 
carbohydrate as a substrate and therefore more lactate would be produced through 
glycolysis (Brooks et al. 2005; Rasmussen & Winder 1997; Romijn et al. 1993; van Loon 
et al. 2001).  Therefore, it was speculated by Evans et al. (2009) that perhaps less 
carbohydrate was being metabolized as an energy substrate and thus causing lower blood 
lactate levels.   
 
Purpose 
The results of the study performed by Evans et al. (2009) indicates that further 
research on substrate oxidation and carbohydrate metabolism in cancer patients during 
exercise is warranted.  Therefore, the purpose of this study was to compare substrate 
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oxidation and blood lactate at low (40% VO2max), moderate (60% VO2max), and high 
(70% VO2max) intensities in post-treated breast cancer patients to apparently healthy 
controls.  The methodology used was similar to the protocol that was used in Evans et al. 
(2009).   In general, post-treated breast cancer patients (women) completed steady-state 
exercise for 9 minutes at low (40% VO2max), moderate (60% VO2max), and high (70% 
VO2max) intensities.  Matched control women with no history of breast cancer also 
performed the same exercise sessions at low, moderate, and high intensities.  Respiratory 
gases, blood lactate, blood glucose, and substrate oxidation measurements were taken 
during and after exercise testing and compared between the cancer treatment and control 
groups.   
 
Significance of study 
 The significance of this study pertains to the development of a better 
understanding of substrate oxidation (i.e., energy metabolism) at different exercise 
intensities in post-treated breast cancer patients and how it compares to healthy women.  
Energy metabolism increases with increasing intensity of exercise (Brooks et al. 2005; 
McArdle et al. 2007).  Concurrently, the amount of carbohydrate used as an energy 
source also increases with greater exercise intensity.  Conversely, the amount of lipid 
decreases as exercise intensity increases and carbohydrate contribution increases.  If 
carbohydrate metabolism is compromised with increasing exercise intensity, it can make 
exercise more difficult and result in an earlier onset of fatigue (Manore &Thompson 
2000).  The fact that carbohydrate metabolism may be altered at rest in cancer patients 
suggests that exercising carbohydrate metabolism may be altered as well.  This 
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possibility warrants that studies examining exercise energy metabolism are necessary in 
cancer populations.  Such studies can provide information and give insight into issues of 
exercise intensity so that more accurate guidelines/recommendations can be developed 
for exercise training prescription in breast cancer patients.   
 
Research questions  
1. Is there a difference in substrate (carbohydrate and lipid) oxidation in cancer patients 
exercising at low (40% VO2max), moderate (60% VO2max), and high (70% VO2max) 
intensities when compared to apparently healthy controls? 
2. Is there a difference in blood lactate response in cancer patients exercising at low (40% 
VO2max), moderate (60% VO2max), and high (70% VO2max) intensities when compared to 
apparently healthy controls? 
3. Is the relationship between carbohydrate oxidation and blood lactate production (post-
exercise) different in breast cancer patients when compared to apparently healthy 
controls? 
 
Hypotheses 
H1. No significant difference in lipid and carbohydrate oxidation will occur between the 
cancer and control groups during low (40% VO2max) and moderate (60% VO2max) 
exercise intensities. 
H2. Carbohydrate oxidation will be significantly lower and lipid oxidation will be 
significantly higher during exercise at high (70% VO2max) intensity in the cancer group 
when compared to controls. 
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H3. No significant difference in the blood lactate response to exercise will occur between 
the cancer and control groups during low (40% VO2max) and moderate (60% VO2max) 
exercise intensities. 
H4. Blood lactate response will be significantly lower post-exercise at the high (70% 
VO2max) intensity in the cancer group when compared to controls. 
H5. A significant correlation will exist between carbohydrate oxidation and blood lactate 
production in both healthy controls and cancer patients in response to exercise; however, 
this relationship will be significantly stronger in the healthy controls.    
 
Delimitations 
Male subjects were excluded from this study and only female subjects were 
studied due to the high prevalence of the disease in women.  All breast cancer patients 
had completed their major treatments including surgery, chemotherapy, radiation, or any 
combination of these treatments within 6 months prior to participating in the study.  This 
study was performed in a thermo-neutral environment to control for the effect of 
increased carbohydrate use due to increased core temperature.  Subjects also refrained 
from consuming any food or beverage two hours before each exercise session to establish 
more accurate resting blood glucose and blood lactate measurements. 
 
Limitations 
This study did include some limitations which may have impacted the results.  
The study used a submaximal test to predict maximal oxygen consumption (VO2 max) 
which was not the most accurate measure of VO2 max because it is based on certain 
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assumptions (e.g., economy of movement, linear HR response, etc).  Protein metabolism 
was not taken into consideration during this study which may have somewhat confounded 
the interpretation of the outcomes of the study.  Diet was not controlled; therefore 
differences in the percentage of carbohydrate and fat consumed may have impacted 
substrate oxidation during exercise.  There was a very small sample size which decreased 
the power of the results.  Lastly, the study results can only be generalized to women who 
have been diagnosed with Stage I – III breast cancer and have completed all major 
medical treatments within the last 6 months. 
  
 
 
 
CHAPTER II 
 
REVIEW OF LITERATURE 
Introduction 
The positive prognosis for breast cancer patients has greatly increased over the 
last decade due to earlier detection and more effective treatments (Battaglini et al. 2008; 
Jones et al. 2007; Humpel & Iverson 2005; Kim et al. 2009).  These improvements 
however, have increased the number of cancer survivors with lingering side effects from 
their treatments (McTiernan 2004).  Exercise training has been shown to be a positive 
therapy to increase overall health and quality of life for many cancer patients during and 
after treatments (Knols 2005).  Substrate metabolism during exercise is studied widely in 
healthy individuals, however currently there is little evidence based information about 
this topic for cancer survivors. 
 
I. Side effects of breast cancer and treatments 
 As the number of breast cancer survivors increases, the impact of treatments on 
long term health and well-being has caused a large population with unique and distinct 
needs (Sternfeld et al. 2009; Stull et al. 2007; White et al. 2009).  The acute and chronic 
side effects of treatment can cause serious and sometimes fatal consequences for this 
growing number of breast cancer survivors.  Side effects of breast cancer and subsequent 
treatments can range anywhere from decreased energy expenditure to increased mortality.  
Most importantly these treatments typically cause a functional decline which increases 
 10 
the risk of recurrence, and co-morbidities such as cardiovascular disease, diabetes, and 
osteoporosis, as well as premature death (Lane & McKenzie 2005; Stull et al. 2007; 
White et al. 2009).   
Cardiovascular injury 
Almost all of the adjuvant therapies have side-effects which at some level may, 
directly or indirectly, acutely or chronically impact the cardiovascular system of cancer 
patients (Jones et al. 2007).  For example, anthracycline is an effective form of 
chemotherapy commonly prescribed to patients; however, it can cause cardiotoxicity 
which is then further complicated by the interaction of other prescribed drugs and 
therapies (Gianni et al. 2008).  The correlation of drug treatment and side effects seems to 
be dose dependent, with patients receiving high or extended doses of medication having a 
greater risk for cardiac complications (McTiernan 2004).  Some of the cardiac damage 
that occurs with these treatments does not result in overt symptomatic events, 
necessitating the need for identifying signs of cardiac damage earlier on (Gianni et al. 
2008).  Long term effects of anthracycline chemotherapy treatment can also cause 
declines in left ventricular function while radiotherapy treatment may cause 
cardiovascular pathologies including atherosclerosis, coronary artery disease, and 
thickening of the pericardium (Jones et al. 2007).    Endocrine therapies such as 
Tamoxifen and biological drug therapies such as Herceptin may also have a negative 
impact on the cardiovascular system including cardiovascular disease and cardiac toxicity 
(Jones et al. 2007).   Courneya et al. (2003) indicate the reduction in cardiopulmonary 
capacity may lead to substantial reductions in quality of life or even premature death.   
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These cardiovascular complications that accompany cancer treatment can be chronic and 
severe and therefore need to be addressed. 
Musculo-skeletal symptoms 
Another side effect of breast cancer treatment is an increased risk for developing 
osteoporosis due to medications use, decreases in physical activity and weight-bearing 
exercises (McTiernan 2004).  Lymphedema is also another side effect associated with 
breast cancer survivors, especially those who have had some lymph nodes removed 
(McTiernan 2004).  Furthermore, both chemotherapy and radiation have been shown to 
cause changes in muscle physiology at the cellular level (Battaglini et al. 2006).  
Specifically, a variety of chemotherapy treatments can cause direct injury to muscle cells 
at the site of treatment while radiation can cause declines in neuromuscular efficiency 
(Billingham et al. 1977; Kuno et al. 1996; Monga et al. 1997).   Inactivity due to fatigue 
also causes muscle atrophy and loss of muscle strength (Humpel & Iverson 2005).  
Fatigue and related symptoms  
The most common complaint of all cancer patients is fatigue, with rates 
occurrence rates ranging as high as 96% (Humpel & Iverson 2005; McTiernan 2004).  
This can be one of the most distressing and persistent symptoms of the disease in breast 
cancer survivors (Courneya et al. 2003; Dimeo et al. 1998).  Other common symptoms 
reported by cancer patients include feelings of anxiety and depression, sleep disturbances, 
decreased physical activity, decreased functional capacity, and decreases in activities of 
daily living (Humpel & Iverson 2005).  Feelings of nausea have also been reported as a 
side effect of treatments (Segal et al. 2001).  Many cancer treatments can also have 
adverse affects on sleep patterns which is associated with “decrements in learning, 
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memory, alertness, and immune function, and may exacerbate anxiety and depression” 
(McTiernan 2004). 
Weight gain 
Weight gain is a common side effect during and after breast cancer treatments 
(Demark-Wahnfried et al. 1997; Kim et al. 2009; Saquib et al. 2007).  This weight gain 
has been attributed to many factors including physical inactivity, decreased resting 
metabolic rate, hormonal changes, overeating, or the disease process itself (Schwartz 
2000).  Interestingly, many women decrease their level of physical activity because they 
are fearful of overexertion or unsure of what exercise they can do (Segal et al. 2001).  It 
has been suggested that cancer treatments, may impair the body‟s ability to process (i.e., 
digest, store) nutrients which could have a profound impact on substrate metabolism and 
weight gain both at rest and during exercise (Battaglini et al. 2006). 
Chemotherapy treatment specifically has been linked to an increased weight gain 
in breast cancer patients although the exact mechanism is not well understood (Demark-
Wahnfried et al. 1997; Saquib et al. 2007; Schwartz 2000).  One theory is that women 
typically gain weight as they transition through menopause; as chemotherapy pushes 
younger women into earlier menopause, there is a substantial increase in body mass 
(Saquib et al. 2007).  Steroid drug use along with chemotherapy is also common which 
may also enhance weight gain (Saquib et al. 2007).  The Women‟s Healthy Eating and 
Living Study reported that women who received chemotherapy were 65% more likely to 
see a significant weight gain after treatment when compared to women who did not 
receive either chemotherapy or Tamoxifen drug treatment (Saquib et al. 2007).   
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To complicate issues, this weight gain typically consists of an increase in 
adiposity and a decrease in lean body mass, causing an increased percentage in body fat 
(Battaglini et al. 2008; Doyle et al. 2006).  This altered body composition can negatively 
impact levels of fatigue, rates of survival and re-occurrence as well as have damaging 
psychological impacts on the patient (Battaglini et al. 2008; Demark-Wahnfried et al. 
1997).  Furthermore, greater levels of visceral fat, especially intra-abdominal fat, have 
been associated with increased levels of glucose and insulin (McTiernan 2004).  Elevated 
levels of insulin have “mitogenic effects on breast cells”, which negatively impacts breast 
cancer prognosis (Larrson et al. 2007; McTiernan 2004).  Additionally, weight gain in 
adulthood has also been shown to increase the risk of developing breast cancer, increased 
recurrence, and higher mortality rate (Demark-Wahnfried et al. 1997; Kim et al. 2009; 
Saquib et al. 2007).   
Results of a large epidemiologic study also showed that less than 10% of breast 
cancer survivors were able to return to their pre-diagnosis weight over 6 years of follow-
up visits (Saquib et al. 2007).  This issue is further complicated by the fact that many 
cancer survivors were already overweight or obese at the time of diagnosis (Doyle et al. 
2006).  It has been well documented that overweight and/or obesity in patients can 
negatively affect their survival rates, especially in breast cancer patients (Kim et al. 2009; 
McTiernan 2004).  Due to the fact that obesity has been strongly associated with breast 
cancer recurrence as well as decreased survival rates, there is an urgent need to help these 
survivors maintain or obtain a healthy weight after completing treatments (Doyle et al. 
2006).   
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II. Benefits of exercise after cancer treatment 
Although the previously mentioned side effects can be detrimental for breast 
cancer survivors, exercise can help patients to improve their overall health and well 
being.  Just as exercise has been used as a complementary therapy in other chronic 
diseases, it has recently been used to help improve quality of life, physical fitness, and 
overall survival rate in breast cancer patients (McNeely et al. 2006).  Historically, 
physicians were recommending cancer patients to rest, in an attempt to help the increased 
fatigue that typically coincides with cancer and its related treatments (Dimeo et al. 1998).  
It is now recognized that such inactivity induces muscular catabolism and was therefore 
further increasing levels of fatigue and inactivity (Dimeo et al. 1998; Evans et al. 2009).  
In recent years, studies have consistently shown that exercise during the recovery from 
cancer treatment can improve cardiovascular fitness, muscle strength, body composition 
and fatigue levels (Doyle et al. 2006; Humpel & Iverson 2005; Speck et al. 2010).  
Lifestyle factors, including physical activity (i.e., exercise training), are now recognized 
as a way to ameliorate side effects from treatment and decrease the chances of recurrence 
and co-morbidities (White et al. 2009).   
Attenuate cardiovascular injury 
The serious impact of cardiovascular injury has been shown to be lessened with a 
combination of exercise and cardiovascular disease drugs. Specifically, these factors have 
resulted in improved vasodilation, lower oxidative stress, and an increase in endothelial 
progenitor cells (Jones et al. 2007).  Jones et al. (2007) reports exercise training can also 
increase cardiovascular reserve, exercise capacity, reduce cardiovascular disease 
mortality, and all-cause mortality.  This concept is supported by a meta-analysis of 
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studies using exercise after breast cancer treatment, which showed improvements in 
blood pressure and cardiopulmonary measures (Knols et al. 2005).  Exercise training in 
breast cancer survivors is also thought to decrease the risk of cardiovascular disease, just 
as in other populations, and therefore improve overall prognosis (Sternfeld et al. 2009).   
Increase aerobic capacity 
Aerobic exercise in a variety of cancer patients, including breast cancer patients, 
has repeatedly shown to increase aerobic capacity (VO2) when compared to non-
exercising patients (McTiernan 2004).  Furthermore, a meta-analysis performed 
specifically in breast cancer patients, showed a moderate to large improvement in 
absolute and relative peak oxygen consumption (VO2peak) (Kim et al. 2009).  Courneya et 
al. (2003) demonstrated that moderate to high aerobic exercise 3 times a week for 15 
weeks showed a significant improvement in absolute and relative VO2peak in 
postmenopausal exercising breast cancer patients when compared with a control group 
who‟s absolute VO2peak decreased.  Although the exact mechanism of this improvement is 
not well understood in breast cancer survivors, it is assumed to be the same as in other 
women through skeletal muscle adaptations (improved capillary density, increased 
oxidative enzymes, ratio of Type I muscle fibers) and increased cardiac output (Courneya 
et al. 2003).  A study similar to that of Courneya et al. (2003) indicated that breast cancer 
patients not receiving chemotherapy, significantly increased aerobic capacity using a 
home based aerobic exercise intervention or a supervised aerobic exercise intervention 
when compared to a control group which saw a decrease in aerobic capacity (Segal et al. 
2001).   
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Exercise intensity may also have an impact on physical functioning, with 
moderate increases seen with training conducted at 50-60% of VO2max, while more robust 
increases may be seen after exercise training at 60-85% of VO2max (Segal et al. 2001).  
However, trying to determine the appropriate exercise intensity to prescribe for cancer 
patients can be difficult.  Most studies have used percentages of heart rate or VO2max or a 
combination of the two but a few studies have used either RPE or blood lactate 
measurements (Evans et al. 2009).  Dimeo et al. (1998) trained cancer patients on the 
treadmill 5 days a week for 6 weeks, just below their anaerobic threshold (3.0 ± 0.5 
mmol/L) at about 80% of maximum heart rate.  To ensure training just below the 
anaerobic threshold was achieved blood lactate concentrations were checked during 
exercise at the end of each training week.  If lactate concentrations fell below 2.5 mmol/L 
during exercise, the treadmill speed was increased 0.5 km/h to maintain the appropriate 
intensity (Dimeo et al. 1998).  Results showed a significant decrease in blood lactate after 
training from 2.6 mmol/L to 1.3 mmol/L at a submaximal workload of 5km/h (Dimeo et 
al. 1998).  This particular study however, only had 5 subjects of varying age and type of 
cancer and some were still receiving major treatments while others had finished their 
treatments up to 18 months before beginning the program.   
Reduce fatigue and related symptoms 
Many psychological benefits have been reported after exercise in cancer survivors 
including significant improvements in mood, fatigue, depression, anxiety, happiness, self-
esteem, and quality of life (Courneya et al. 2003; Doyle et al. 2006; Knols et al. 2005).  
Courneya et al. (2003) reported similar results with an aerobic exercise intervention in a 
cancer group compared to non-exercising cancer patients.  It is important to note however 
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that the changes in self-esteem were independent of cardiovascular changes and may be 
related to social interaction or a sense of accomplishment by completing the exercise 
program (Courneya et al. 2003).  Segal et al. (2001) and McNeely et al. (2006) also report 
improved degrees of nausea, self-image, and physical functioning in response to exercise 
training.   Increased levels of daily exercise may also be used as a mechanism to control 
stress after breast cancer treatments to help patients cope with the disease as well as have 
some self-control during the treatment process (Segal et al. 2001).   
Musculo-skeletal improvements 
Weight bearing aerobic activity in cancer patients, has been shown to increase 
muscle mass, increase joint lubrication, and reduce fracture occurrence in elderly patients 
through improved balance and stability (McTiernan 2004).  Weight bearing aerobic 
exercise has also been shown to significantly decrease the amount of bone density lost in 
cancer patients when compared with control subjects (McNeely 2006).  Exercise training 
in cancer patients has a positive impact on protein synthesis and muscle regeneration 
(Battaglini et al. 2006).  Specific exercises to increase range of motion for breast cancer 
survivors may also improve connective tissue integrity and help to decrease joint pain 
(Battaglini et al. 2006).  More research is needed to confirm or refute these preliminary 
findings.  
Increased survival rate 
Some studies have reported that physical activity (i.e., exercise) significantly 
decreases breast cancer recurrence and death rates (Doyle et al. 2006).  Although, this 
was not found in the Life After Cancer Epidemiology (LACE) study, physical activity did 
seem to have a protective effect on total mortality in breast cancer patients regardless of 
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stage of cancer, menopausal status, and body mass index (BMI) (Sternfeld et al. 2009).  
Interestingly, vigorous exercise did not seem to show a protective effect with breast 
cancer recurrence, mortality or all cause mortality when compared to moderate exercise 
(Sternfeld et al. 2009).  Improved cardiovascular fitness has been associated with 
decreased all cause mortality in healthy women and therefore may also positively impact 
breast cancer survivors (McNeely et al. 2006).  Exercise training in breast cancer 
survivors is also thought to improve prognosis through improved immune function 
(Sternfeld et al. 2009).   
Weight management 
There is a strong correlation between increased body fat, re-occurrence rates and 
decreased survival (Battaglini et al. 2008; McTiernan 2004).  Decreased total caloric 
intake during treatment can cause a loss of lean tissue with an increase in percent body fat 
(Battaglini et al. 2008).  Exercise in breast cancer patients during treatment has shown to 
increase appetite and cause less of an increase in body fat percentage and body mass 
(Battaglini et al. 2006, 2008; Schwartz 2000).  Battaglini et al. (2008) examined patients 
who participated in aerobic and resistance exercise training throughout their cancer 
treatment.  Patients who exercised had a significantly higher total caloric intake, less of 
an increase percent body fat and a lower fatigue level at the end of the treatment period 
when compared with patients who did not exercise.  Schwartz (2000) also examined 
patients who were undergoing treatment and stratified the subjects as exercisers or non-
exercisers based on caloric expenditure as measured with an accelerometer.  The study 
found that the non-exercisers had an increase in weight and BMI throughout treatment 
while the exercisers maintained their weight and BMI (Schwartz 2000).  Specifically 
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during major medical treatments, a combination of exercise and diet may have a greater 
impact on body composition than exercise alone (McTiernan 2004).   
The results of multiple studies indicate that after major medical treatments have 
been administered, physical exercise alone is not enough to cause a significant decrease 
in weight (Knols et al. 2005).  One study focusing on aerobic exercise in breast cancer 
patients showed no improvements in body weight or BMI after treatment when compared 
to controls, but there was a trend toward improved body composition through decreased 
sum of skinfolds (Cournyea et al. 2003).  Segal et al. (2001) reported that breast cancer 
patients undergoing supervised aerobic exercise training program during treatment 
decreased body weight but it was not significant when compared to a control group.  
More specifically, the patients that had undergone chemotherapy only saw a small non-
significant decrease in body weight with exercise while the control group had an increase 
in body weight (Segal et al. 2001).  A meta-analysis of breast cancer studies also revealed 
a non-significant reduction in both body weight and BMI after exercise when compared 
to a control group (McNeely et al. 2006).  Another meta-analysis of breast cancer studies 
showed that exercise intervention significantly decreased body fat percentage but did not 
have a significant impact on body weight or lean body mass (Kim et al. 2009).  Aerobic 
exercise alone compared to aerobic and resistance training combined showed a smaller 
effect size on lean body mass and body fat percentage (Kim et al. 2009).  Solely aerobic 
exercise may be more beneficial at reducing body weight in more specific sub-groups 
that have a higher likelihood of weight gain, such as, younger women receiving 
chemotherapy (Kim et al. 2009).   
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Conclusions 
Current data show an overall beneficial effect of exercise training in cancer 
patients on a variety of physiological and psychological markers (Knols et al. 2005; 
McTiernan 2004). These results however are not found in all trials and therefore the 
findings should be interpreted carefully (Knols et al. 2005).  The benefits of exercise may 
be affected by mode, intensity, and duration of the exercise program as well as the 
patient‟s baseline measurements, lifestyle, motivation, and adherence to the program 
(Knols et al. 2005).  Precise exercise prescriptions for exercise training programs are still 
unclear due to the variety of types of cancer, stage of cancer, type of treatment, age of 
patient, and other confounding factors (Humpel & Iverson 2005).  Even in breast cancer 
patients there is a wide variety of exercise prescribed due to the “lack of consensus on 
optimal exercise prescription for this patient population” (McNeely et al. 2006).  More 
evidence-based research is necessary to help answer these questions as well as develop 
more precise exercise prescription guidelines (Humpel & Iverson 2005; McTiernan 
2004).   
 
III. Substrate metabolism (lipid and carbohydrate oxidation) 
A. Healthy individuals during exercise 
Exercise energy produced through substrate oxidation has been studied extensively in 
healthy individuals.  Carbohydrate and fat are the primary substrates oxidized during 
exercise to produce energy and these substrates are used at different rates depending on 
exercise intensity (Brooks et al. 2005; van Loon et al. 2001).  Other factors impacting the 
rate and amount of substrate oxidation include diet, muscle glycogen content, exercise 
duration, training status, fiber type make-up, and blood metabolites (Venables et al. 
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2005).  Fuel utilization during exercise is a complex process but it seems as though the 
amount of substrate available and enzyme activation play the key role in healthy trained 
individuals (Rasmussen & Winder 1997; van Loon et al. 2001).   
Carbohydrate is the primary substrate oxidized with increasing exercise intensity, 
while free fatty acid oxidation decreases (Rasmussen & Winder 1997).  It is believed that 
the mechanism which causes decreased fat oxidation during high intensity exercise is an 
increased amount of glycolytic activity, decreased activity in the pyruvate dehydrogenase 
complex, decreasing the amount of free carnitine available, and limiting the amount of 
free fatty acids transferred into the mitochondria (van Loon et al. 2001).  This decrease in 
available free carnitine at high intensity may also then limit the amount of carnitine 
palmitoyltransferase (CPT 1) enzyme activity which would also in turn reduce the 
amount of fat oxidation (van Loon et al. 2001). 
The “crossover concept” has been identified as the point at which the relative amount 
of carbohydrate (CHO) utilized exceeds the relative amount of fats being oxidized and 
occurs in most trained individuals at about 65% VO2max (Rasmussen &Winder 1997).  
However, in untrained men and women, this crossover point occurs much earlier at about 
50% VO2max (Venables et al. 2005).  Relative to untrained persons, evidence suggests that 
the crossover point seems to occur at a significantly higher intensity in women, at about 
54% VO2max, when compared to men, at about 43% VO2max (Venables et al. 2005).   
High amounts of lactate in the blood are also associated with increasing exercise 
intensity and increasing utilization of carbohydrate as an energy substrate (Rasmussen 
&Winder 1997).  Initially with low to moderate intensity exercise there is a small but 
linear increase in blood lactate levels.  However, as exercise intensity moves from 
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moderate to hard/heavy, lactate levels tend to increase exponentially (Brooks et al. 2005).  
Increases in blood lactate can have both direct and indirect effects on limiting fat 
oxidation and utilization (Venables et al. 2005). 
B. Cancer patients 
Early studies have indicated that altered carbohydrate metabolism has been 
consistently recognized in cancer patients (Edmonson 1966; Glicksman & Rawson 1956; 
Marks & Bishop 1956; Warburg 1956).  Warburg (1956) was the first to discover that 
lack of oxygen or toxic substances can irreversibly destroy cellular respiration in normal 
cells.  Over time, the cells use anaerobic glycolysis to survive and altered cells, otherwise 
known as cancer cells are formed (Warburg 1956).  The phenomenon of cancer tumor 
cells using anaerobic glycolysis to produce energy even in the presence of oxygen has 
been termed the “Warburg effect” (Levin & Gevers 1981).  This was the first conclusive 
study stating that cancer cells thrived through altered carbohydrate metabolism.   
Multiple studies have shown that glucose intolerance is apparent in 37-60% of cancer 
patients (Levin & Gevers 1981).  A study by Edmonson (1966) indicated that glucose 
tolerance was significantly reduced and the level of glucose needed to suppress plasma 
free fatty acids was significantly higher in cancer patients compared to controls.  
Typically, increases in free fatty acid mobilization are seen after altered carbohydrate 
metabolism through either fasting or Type II diabetes (Edmonson 1966).  Therefore 
altered carbohydrate metabolism in cancer patients may be impacted by hormonal 
alterations, much as is seen in diabetes.  Glicksman and Rawson (1956) speculate that 
altered carbohydrate metabolism may come from a hormonal disturbance due to the fact 
that hyperglycemia is more evident in patients with cancer of endocrine organs.  Other 
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studies have also attributed altered carbohydrate metabolism in cancer patients to insulin 
resistance (Levin & Gevers 1981).  Specifically in breast cancer, high levels of insulin 
also have direct affects on breast tissue and may also indirectly affect breast cancer 
through interactions with other hormones (Larrson et al. 2007).   
A recent study by Evans et al. (2009) exercised post-treated breast cancer patients and 
age-matched healthy controls at low (40% VO2max), moderate (60% VO2max) and high 
(70% VO2max) exercise intensities for 9 minutes.  Results indicated that there were no 
differences in heart rate or rating of perceived exertion between groups across all exercise 
intensities.  There was also no difference in blood lactate results between the groups 
when exercising at low and moderate intensities.  However, breast cancer patients 
exercising at a high intensity (70% VO2max) produced significantly lower blood lactate of 
3.3 mmol/L when compared to age-matched healthy controls with a blood lactate of 7.7 
mmol/L (Evans et al. 2009).  These results were unexpected and were attributed to 
subject age, menopausal status, and menstrual cycle phase differences between the 
subject groups (Evans et al. 2009). Nevertheless, these particular findings suggest that 
carbohydrate metabolism during exercise may not be similar in breast cancer survivors 
when compared to apparently healthy controls.   
Collectively, the above studies suggest an association between altered carbohydrate 
metabolism and cancer. Nonetheless, this relationship is not fully understood and 
therefore more studies investigating this metabolic phenomenon are necessary to 
elucidate the issue.    
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IV. Using indirect calorimetry to predict substrate oxidation 
A. Healthy individuals during exercise   
Indirect calorimetry is used frequently in exercise physiology as a means to determine 
oxygen exchange within the body.  It is assumed that during indirect calorimetry the 
measured oxygen uptake (VO2) and carbon dioxide production (VCO2) are reflective of 
gas exchange at the tissue level (Romijn et al. 1992, 1993).  Specific metabolic 
calculations can then be used to determine substrate oxidation from these measurements 
(da Rocha et al. 2006).  However, when using indirect calorimetry to predict substrate 
oxidation, other metabolic processes such as gluconeogenesis, lipogenesis, ketogenesis, 
and oxidation of lactate need to be considered as they may impact on results (Frayn 1983; 
Romijn et al. 1992).  Typically during exercise these other metabolic processes are not 
occurring at any great extent; they occur more so during the recovery period (Romijn et 
al. 1992).  Another limitation of using indirect calorimety to predict substrate oxidation is 
that it does not include protein oxidation; however, during high intensity exercise very 
little energy is elicited from protein oxidation (Romijn et al. 1992).   
Using indirect calorimetry to measure VO2 by the muscle has been verified but 
there is some controversy that at high exercise intensities increased VCO2 values through 
hyperventilation may overestimate the amount of carbohydrates oxidized (Romijn et al. 
1993).  When exercise intensity goes above the blood lactate threshold, the bicarbonate 
pool may become unstable, therefore over predicting VCO2 and carbohydrate oxidation 
(Romijn et al. 1992).  It is assumed that utilization of VCO2 to predict actual carbon 
dioxide production in the muscle is only beneficial when a subject is exercising at “low” 
or “moderate” steady-state intensities with a stable bicarbonate pool (Venables et al. 
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2005).  When lactate is produced and not oxidized, oxygen and carbon dioxide are not 
directly involved, but the hydrogen ions produced from lactate may displace carbon 
dioxide from bicarbonate stores (Frayn 1983).  During exercise however, lactate is 
typically oxidized or converted to glucose which is then oxidized therefore resulting in 
similar respiratory gases (Frayn 1983; Romijn et al. 1992).  Romijin et al. (1992) further 
illustrated this point and validated the use of indirect calorimetry to calculate 
carbohydrate and fat oxidation in trained healthy men exercising at a “high” intensity 
above their lactate threshold at 85% of VO2max. 
The respiratory exchange ratio (RER) is a ratio of the amount of VCO2 by the 
amount of VO2.  The ratio can be measured through indirect calorimetry procedures.  The 
RER can be assessed during rest or exercise and subsequently used to determine exercise 
energy metabolism, providing information on substrate oxidation and utilization (Brooks 
et al. 2005; McArdle et al. 2007).  As the values increase from 0.70 to 1.00 more 
carbohydrate is being oxidized and less fat is being oxidized with equal amounts (i.e., 
50% CHO, 50% fat) being oxidized at 0.85 (McArdle et al. 2007).  During exercise VO2 
and RER together can be used to calculate how many calories are being utilized for 
energy production.  It is known that carbohydrate contains 4.02 kcal per gram while fat 
contains 8.93 kcal per gram (McArdle et al. 2007).  Therefore carbohydrate and fat 
oxidation can be determined by multiplying the amount of calories expended each minute 
by the percentage of each substrate being oxidized.  The amount of carbohydrate and fat 
oxidized each minute is then divided by 4.02 and 8.93 to come up with amount in grams, 
respectively.    
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B. Clinical populations at rest and during exercise 
 Indirect calorimetry has been used extensively in healthy populations but has also 
been beneficial for clinical populations.  Disease states can have significant impacts on 
nutritional status and therefore indirect calorimetry has been used in clinical populations 
to determine energy expenditure and substrate oxidation at rest (da Rocha et al. 2006).  
Indirect calorimetry can be used in a variety of patients including those that are critically 
ill, such as cancer patients, to use predictive equations of energy expenditure as well as 
determine substrate oxidation (Holdy 2004; Reeves et al. 2004).  This technique is 
typically used in combination with nutritional counseling in an effort to determine total 
energy expenditure and substrate utilization in a wide variety of clinical patients (Holdy 
2004).   
Current work by da Rocha et al. (2006) supports the use of gas exchange to assess 
metabolic alterations in clinical populations and also to monitor a patient‟s nutritional 
status at rest.   Demark-Wahnefried et al. (1997) used indirect calorimetry to determine 
resting metabolic rate in Stage I - II breast cancer patients at various stages throughout 
their chemotherapy treatments.  While most of the previous studies were performed at 
rest, the American College of Sports Medicine (ACSM) suggests that respiratory gases, 
specifically VCO2 and RER may be used in clinical populations during exercise to 
determine substrate oxidation (ACSM 2009).   Therefore using indirect calorimetry to 
predict substrate oxidation during exercise in cancer patients seems to be a valid 
procedure.  
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Conclusion 
It is apparent that exercise has a positive impact on breast cancer survivors in 
many ways.  As research continues however there will be a better understanding of how 
exercise impacts a cancer survivor‟s physiology.  Yet, some questions still remain as to 
how cancer or cancer treatments may cause physiological changes which can affect 
exercise metabolism.  More specifically it is unclear if cancer, or treatment of cancer, 
alters substrate oxidation which could impact a patient‟s ability to exercise at certain 
intensities.  Therefore the purpose of this study will be to explore how cancer and 
subsequent treatments may alter substrate oxidation during exercise in an attempt to 
elucidate this issue.
  
 
 
 
CHAPTER III 
 
METHODOLOGY 
Subjects  
Cancer patients for this study were recruited from the Get REAL and HEEL 
program on the UNC – Chapel Hill campus (i.e., treatment group).  Participants in the 
program ranged from 25 – 75 years old and had been diagnosed with Stage I – Stage III 
breast cancer.  All major medical treatments had been completed within the last 6 months 
prior to enrollment in Get REAL and HEEL.  Women for the healthy control group were 
recruited from the Chapel Hill town area and were matched to patients in the treatment 
group based on age, physical activity, and menopausal status. 
This human subjects study was approved by the Internal Review Board (IRB) at 
UNC – Chapel Hill.  Before agreeing to the study, all subjects met with the primary 
investigator to go over the experimental protocol.  Subjects were informed of all risks 
associated with the study and then were allowed to read and sign the informed consent 
form.  They were also given a physical activity questionnaire (PAQ; modeled after the 
modifiable activity questionnaire) assessing activity levels over the past year (Kriska 
1997).  Subjects completed the PAQ (Appendix A) at the first meeting and scores from 
the questionnaire were used in matching the breast cancer patients with healthy controls.  
All breast cancer patients were cleared by their personal physician to participate in 
physical activity while all control subjects completed a physical screening and 12-lead 
resting ECG at the Applied Physiology Laboratory (APL) for clearance to participate.  
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All subjects were given pre-assessment guidelines to follow before any exercise testing 
occurred.  The guidelines included no exercise 24 hours prior to testing, no alcohol 
consumption 48 hours prior to testing, no eating 2 hours prior to testing, and no diuretics 
taken 7 days before testing unless prescribed by a physician.  Subjects were excluded 
from the study based on the following criteria; an abnormal ECG, a recent history of 
smoking (quit ≤ 2 years ago), any known metabolic disease, acute or chronic illness, 
elevated resting vitals, physical injury, or inability to complete a submaximal cycle 
ergometer test. 
 
Instrumentation   
Subjects‟ height and weight were measured on a portable stadiometer 
(Perspectives Enterprises, Portage, MI) and mechanical scale (Detecto, Webb City, MO), 
respectively.  Lange calipers (Beta Technology, Santa Cruz, CA) were used to take skin 
fold measurements to estimate body composition.  Blood oxygen saturation levels were 
measured using a 3301 model BCI International pulse oximeter (BCI International, 
Waukesha, WI).  All exercise sessions were performed on a Corival model, “Lode” 
electronically braked cycle erogmeter (Lode BV, Groningen, The Netherlands).  Heart 
rate was obtained through a Polar® heart rate monitor (Polar Electro, Inc., Lake Success, 
NY).  An Oro-Nasal 7400 VMask facemask (Hans Rudolph, Inc., Shawnee, KS) with 
headgear was used to collect respiratory gases.  Respiratory gas was analyzed through 
indirect calorimetry with a Parvo Medics TrueMax2400 Metabolic System (Parvo 
Medics, Salt Lake City, UT).  An Accu-Chek Softclix Pro lancet device (Hoffmann-
LaRoche Ltd., Basel, Switzerland) was used to obtain a small blood sample from the 
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finger for analysis.  A “Lactate Plus” lactate analyzer (Nova Biomedical, Waltham, MA) 
was used for all blood lactate measurements.  A “One Touch Ultra” glucometer 
(Lifescan, Inc., Milpitas, CA) was used for all blood glucose measurements. 
 
YMCA test (maximal oxygen uptake) 
Once the subjects had been cleared for participation they reported to the APL for 
their first exercise test.  This test was used to estimate their VO2max value.  Once in the 
laboratory, subjects sat down with a researcher to record menstrual status and verify that 
pre-assessment guidelines had been followed.  The subjects then underwent a brief 
orientation with the equipment and reviewed the procedure for that day. Subjects were 
then fit with a heart rate monitor and asked to rest in a seated position for 5 minutes.  
After 5 minutes of quiet rest, heart rate (HR), blood pressure (BP), and blood oxygen 
saturation levels (SpO2) were recorded.  Once resting HR was recorded, 70% of heart rate 
reserve (HRR) was calculated using the Karvonen formula. Subjects did not continue 
with the exercise session if any of the following resting vitals were observed:  
 HR ≥ 100 bpm (beats per minute) 
 Systolic BP ≥ 140 mmHg 
 Diastolic BP ≥ 90 mmHg 
 SpO2 saturation ≤ 90% 
Age, weight, and height were recorded and then skin fold measurements were taken at 3 
sites (triceps, suprailiac, and abdomen) to determine body composition using the Jackson 
and Pollock equation for women (as reported by ACSM 2009; Evans et al. 2009).   
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For cycle ergometry, each subject was fit onto the ergometer and the seat height 
was adjusted so that there was a 5 – 10° bend in the knee of the extended leg.  Seat height 
was recorded at the end of exercise for future sessions.  They were also fit with a „7400 
Vmask‟ facemask secured tightly around their head which was worn throughout the 
testing to collect respiratory gases.  Resting respiratory gases were taken for 3 – 5 
minutes while the subject was seated in a resting position on the ergometer.  The 
participant then immediately began a 3 – 5 minute warm-up at a low intensity (25 Watts) 
on the electric cycle ergometer. 
 The testing protocol consisted of the YMCA submaximal test as described by the 
American College of Sports Medicine (ACSM) guidelines (2009).  All subjects began the 
first 3 minute stage at 25 Watts (W).  Heart rate was recorded during the last 15 seconds 
of the 2
nd
 and 3
rd
 minute of each stage while the rating of perceived exertion (RPE) was 
recorded during the last 30 seconds of each stage using Borg‟s (6–20) scale.  If the 
subjects‟ recorded HR was within 5 bpm between the 2nd and 3rd minute of the stage, the 
subject then moved on to the next stage.  If the subject‟s HR was greater than 5 bpm 
difference between the 2
nd
 and 3
rd
 minute of the stage, they continued for a 4
th
 minute.  
The HR between the 3
rd
 and 4
th
 minute was compared and had to fall within 5 bpm to 
proceed to the next stage.  This was done to verify that the subject had achieved a steady 
state response at each stage.  The workload of the 2
nd
 stage was determined by the steady-
state HR attained in the first stage as seen below: 
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STAGE 1: 25 W 
HR: < 80 HR: 80 - 90 HR: 90 - 100 HR: > 100 
STAGE 2 125 W 100 W 75 W 50 W 
STAGE 3 150 W 125 W 100 W 75 W 
Table 1 – Chart used during the YMCA test to determine workload after the first stage. 
The exercise test continued until the subject completed 2 stages in which their HR was 
between 110 bpm and 70% of their HRR.  The exercise test was also terminated if the 
subject obtained a HR > 150 bpm, they could not maintain the workload, the subject 
requested to stop, or the investigator felt that the test should be terminated for safety 
reasons. 
 Immediately after the exercise test was over the workload was reduced to 20W for 
a cool down of 3 – 5 minutes.  During the cool down period the subject was able to 
remove the facemask and consume fluids ad libitum.  Vital signs were continually 
monitored throughout the recovery period and the subject was able to stop pedaling and 
dismount the bike when vitals had appreciably decreased and stabilized.  Subjects were 
cleared to leave the APL when HR was ≤ 100 bpm, systolic BP was within 20 mmHg of 
resting values, SpO2 was within 5% of resting values, and they were showing no other 
signs of distress or discomfort. 
 
Calculations 
 Based on the results of the YMCA submaximal test, the subject‟s predicted 
maximal workload was determined using a regression equation of workload versus HR 
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response.  This workload was then used to predict VO2max using the ACSM equation: Leg 
cycling VO2 (ml/kg/min) = [1.8 x work rate (kgm/min)]/body mass (kg) + 3.5 
(ml/kg/min) + 3.5 (ml/kg/min) (ACSM, 2009).  A regression of actual and predicted 
workloads and VO2 values was used to prescribe workloads for submaximal exercise 
sessions.  Specifically, each subject completed 3 submaximal exercise sessions that 
corresponded with 40% (low intensity), 60% (moderate intensity), and 70% (high 
intensity) of their predicted VO2max. The three exercise sessions were randomly assigned 
to each subject in an attempt to decrease confounding outcomes.  Subjects returned 2 – 7 
days after the YMCA protocol test to begin their submaximal exercise sessions.   
 
Exercise sessions 
For all cancer patients enrolled in the Get REAL and HEEL program, the exercise 
sessions were used as the cardiovascular training portion of their workout for that day.  
Subjects returned to the APL at least 48 hours after their YMCA test for their first 
submaximal exercise session.  Once at the laboratory, subjects put on a heart rate monitor 
and sat upright in a resting position for several minutes.  During this rest period, they 
were prompted by the investigator to complete a 24-hour recall of their diet (Appendix 
B). The information from the dietary recall was entered into the website, 
http://www.sparkpeople.com, to determine total caloric intake, percentage of 
carbohydrate and percentage of fat consumed in the previous 24 hours.  This was 
performed to ensure that the subjects were in a eucaloric state and that their carbohydrate 
intake was within a normal range of 45 – 55% of daily caloric intake (Manore & 
Thompson 2000).  The investigator also confirmed that the subjects had been fasting for 
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the past 2 hours and documented any changes in the subject‟s menstrual status. Next, the 
equipment use and exercise protocol for the day was reviewed with the subjects.  Resting 
HR, BP, and SpO2 were recorded, and just as with the YMCA submaximal test, the 
exercise session did not progress forward if HR ≥ 100 bpm, systolic BP ≥ 140 mmHg, 
diastolic BP ≥ 90 mmHg, or SpO2 ≤ 90% were observed.  A resting blood lactate and 
blood glucose sample were then taken using a finger puncture technique and immediately 
analyzed (described in Blood analysis section).   
 The subject then positioned themselves on the electric cycle ergometer and 
secured the facemask tightly around their head to collect resting metabolic data for 3 – 5 
minutes.  Once the calorimetry system had stabilized, the subject then began a 3 – 5 
minute warm-up period at 20W on the electric cycle ergometer. Exercise sessions 
consisted of 9 minutes of steady-state exercise at the randomly chosen prescribed 
workload for the day and started immediately after the warm-up (Evans et al. 2009).  All 
subjects were blinded to the specific exercise workload for each session.  The exercise 
protocol lasted for 9 minutes or until the subject could not maintain the workload, the 
subject requested to stop, or the investigator felt that the exercise session should be 
terminated for safety reasons.  Indirect calorimetry was performed throughout the 
exercise session with respiratory gas analysis updated every 15 seconds. Heart rate and 
RPE were taken during the last 15 seconds of every minute during the exercise session to 
ensure safety.   
 Following the submaximal exercise, the workload was reduced to 20W for a cool-
down of 2 minutes and the facemask was removed.  At the end of the 2
nd
 minute of the 
cool-down the subject was asked to stop pedaling and remain seated on the cycle 
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ergometer.  A final blood lactate and blood glucose measurement were taken during the 
last 30 seconds of the 3
rd
 minute into recovery.  Once the last blood sample had been 
taken the subject was able to consume fluids and dismount the cycle ergometer.  Vital 
signs were continually monitored throughout the recovery period and the subject was 
cleared to leave the APL when HR was ≤ 100 bpm, BP was within 20 mmHg of resting 
values, SpO2 was within 5% of resting values, and they were showing no other signs of 
distress or discomfort.  Get REAL and HEEL participants were then transported to the 
clinic for the remainder of their exercise session for the day.  The same protocol was 
repeated twice more, with at least 48 hours between sessions, over the next 2 weeks. 
 
Blood analysis   
Finger punctures were used throughout the testing for blood analysis.  For resting 
measurements the fingertip was placed in a cup of warm water to increase blood flow to 
the area.  The fingertip was dried and then cleaned with an alcohol pad to remove dirt and 
debris.  The area was then wiped with a sterile gauze pad to remove any residue of sweat 
or alcohol.  A lancet device was set with a depth setting of 3 – 5 for the skin puncture.  
The finger was punctured using the lancet and the finger was massaged distally until a 
small bead of blood appeared.  A blood lactate measurement was taken first and a blood 
glucose measurement was taken immediately afterwards from the same site.  If possible a 
duplicate blood lactate sample was also taken.  The finger puncture was then covered 
with a sterile gauze pad and the subject was asked to add some compression for about 1 – 
2 minutes or until bleeding stopped.  These steps were replicated for the resting and post-
exercise blood sampling.  After the exercise session additional first-aid care was provided 
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to the subject as needed.  The biochemical basis for the lactate analyzer and glucometer 
analytical procedures are reported in the appendices (Appendices C and D).  
 
Respiratory gas analysis   
Both the oxygen uptake (VO2) and respiratory exchange ratio (RER) were 
averaged for the last 5 minutes (min 4 – min 9) of the 40%, 60%, and 70% exercise 
sessions.  If the subject did not complete all 9 minutes, only the minutes completed after 
4 minutes were averaged.  Based upon these averages the amount of calories expended 
per minute was calculated.  The RER data was then broken down into the percent of 
lipids and carbohydrates oxidized per minute (McArdle et al. 2007).  Finally the total 
amount of grams oxidized per minute for each substrate was calculated for the 5 minute 
steady state period (McArdle et al. 2007).  An example of these calculations appears in 
Appendix E. 
 
Statistical analysis  
  All statistical procedures were performed using version 17.0 of Statistical 
Package for the Social Sciences (SPSS) software (SPSS Inc, Chicago, IL). Statistical 
significance was set a priori at an α level of p ≤ 0.05.  A one-way ANOVA was run on 
the demographic characteristics of the 2 groups.  For the metabolic data a 2 x 3 mixed 
model ANOVA (group x intensity) was applied on the rate of lipid and carbohydrate 
oxidation (g/min) averaged over the last 5 minutes of steady-state submaximal exercise 
sessions.  A Tukey HSD post hoc test was used to determine mean differences when a 
significant effect was found (hypotheses - H1, H2).  A 2 x 3 x 2 mixed model ANOVA 
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(group x intensity x time) was also applied on blood lactate measurements.  A Tukey 
HSD post hoc test was used to determine mean differences if a significant effect was 
found (hypotheses - H3, H4).  A Pearson product moment correlation was run between 
carbohydrate oxidation and recovery blood lactate over all 3 exercise intensities within 
each of the groups (hypothesis - H5).  A Hotelling test was applied between groups to 
determine if the correlation for each group was significantly different (hypothesis - H5). 
  
 
 
 
CHAPTER IV 
 
RESULTS 
Subjects 
 There were 14 subjects who participated in the study; seven women in the 
treatment group and seven women in the control group.   All women in the treatment 
group had been diagnosed with breast cancer, undergone surgery and had completed their 
major medical treatments within the last six months.  One woman had been diagnosed 
with Stage I breast cancer while three subjects had been diagnosed with Stage II and 
three subjects had been diagnosed with Stage III breast cancer.  Four of the women 
received both chemotherapy and radiation treatment, while one woman received only 
chemotherapy and two women received only radiation therapy as their major medical 
treatments.  Six out of the seven women in the treatment group were also on adjunctive 
therapies (i.e., Herceptin, Tamoxifen, Femara) during this research study.  All women in 
the control group did not have a history of cancer or any pre-existing medical conditions 
that restricted them from exercising and had been essentially sedentary for the last year.   
The subject groups were matched on age (± 4 years; range 38 – 66 years), 
physical activity level and menopausal status.  There were no significant differences (p > 
0.05) between the groups for these characteristics (Table 2).    Although the groups were 
not specifically matched for height, weight, body mass index (BMI), or body fat 
percentage, there was no significant difference between groups for any of these 
parameters either (Table 3).   
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Group Age (yr) 
Activity Level 
(MET h/wk) 
Menopausal status  
(# of women) 
Treatment 50.6 ± 3.3 77 ± 6 
Pre-menopausal (1) 
Peri-menopausal (3) 
Post-menopausal (3) 
Control 50.9 ± 3.6 65 ± 10 
Pre-menopausal (3)  
Peri-menopausal (2) 
Post-menopausal (2) 
Table 2 – Matching factors characteristics (mean ± SE). 
Group 
Height 
(cm) 
Weight 
(kg) 
BMI 
(kg/m
2
) 
Body fat 
(%) 
 
Treatment 
 
166.5 ± 2.6 81.6 ± 4.2 28.6 ± 1.1 31.8 ± 1.6 
 
Control 
 
162.8 ± 1.6 75.4 ± 5.4 28.2 ± 1.9 31.2 ± 2.2 
Table 3 – Subject physical characteristics (mean ± SE). 
Subjects were asked to consume their typical diet over the course of the research 
study and a 24 hour dietary recall was administered before each submaximal exercise 
session to confirm dietary intakes.  There were no significant differences (p > 0.05) for 
total caloric intake, percentage of carbohydrates (CHO) consumed, or percentage of fat 
consumed between groups at each submaximal exercise session (Table 4). 
Prescribed 
Intensity 
Group 
Total Caloric Intake 
(kcal) 
CHO 
(%) 
Fat 
(%) 
Low 
(40% VO2max) 
Treatment 1942 ± 205 51 ± 5 33 ± 4 
Control 1878 ± 298 52 ± 3 34 ± 3 
Moderate 
(60% VO2max) 
Treatment 1940 ± 166 52 ± 4 31 ± 3 
Control 1813 ± 305 57 ± 4 28 ± 5 
High 
(70% VO2max) 
Treatment 2207 ± 259 53 ± 5 28 ± 4 
Control 1479 ± 148 56 ± 3 30 ± 4 
Table 4 – Subject dietary intake 24 hours prior to each submaximal exercise session 
(mean ± SE). 
 
 
 
 40 
YMCA test (maximal oxygen uptake) 
The results of the YMCA test to predict VO2max are reported in Table 5.  
Furthermore, Table 5 also displays the calculated workloads measured in Watts (W) to 
elicit the low (40%VO2max), moderate (60% VO2max), and high (70% VO2max) 
submaximal exercise sessions for each of the subjects.  The predicted VO2max, the 
predicted maximal workload, and workloads at all of the submaximal exercise intensities 
were not significantly different between groups (p > 0.05).   
Group 
VO2max 
(ml/kg/min) 
Wkldmax 
(W) 
Low 
40% VO2max 
(W) 
Moderate 
60% VO2max 
(W) 
High 
70% VO2max 
(W) 
 
Treatment 
 
22.0 ± 1.5 108 ± 6 39 ± 4 61 ± 4 75 ± 5 
 
Control 
 
24.1 ± 1.7 115 ± 10 43 ± 4 69 ± 5 79 ± 6 
Table 5 – Maximal aerobic capacity (VO2max), maximal workload (Wkldmax), and 
workload for each submaximal exercise session (mean ± SE). 
 
 
Submaximal exercise sessions 
 Table 6 presents the actual measured percentage of VO2max and percentage of 
Wkldmax across the different submaximal exercise intensities.  While there are slight 
variances in the percentage of the exercise sessions when expressed as a percentage of 
VO2max or maximal workload, no significant differences were noted between the groups 
for the respective submaximal exercise sessions (p > 0.05).   
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Prescribed 
Intensity 
Group 
Actual Intensity 
(%VO2max) 
Actual Workload 
(% Wkldmax) 
Low 
(40% VO2max) 
Treatment 41 ± 5 36 ± 4 
Control 45 ± 2 37 ± 2 
Moderate 
(60% VO2max) 
Treatment 55 ± 4 57 ± 3 
Control 59 ± 2 60 ± 2 
High 
(70% VO2max) 
Treatment 65 ± 5 70 ± 2 
Control 65 ± 2 69 ± 2 
Table 6 – Actual percentage of VO2max and Wkldmax during each submaximal exercise 
session (mean ± SE). 
 
 During the submaximal exercise sessions there was a significant (p ≤ 0.05) main 
effect of intensity on both heart rate (HR) response and rating of perceived exertion 
(RPE).   However, there was no significant difference between HR response (mean ± SE) 
for the treatment group (120 ± 6, 130 ± 5, 147 ± 5 bpm) versus the control group (115 ± 
4, 135 ± 4, 145 ± 4 bpm; p > 0.05) group at the low, moderate, and high submaximal 
exercise intensities respectively.  Similarly, RPE responses (mean ± SE) for the treatment 
group (11 ± 1, 13 ± 1, 14 ± 1) versus the control group (10 ± 1, 12 ± 1, 14 ± 1; p > 0.05) 
did not differ at the low, moderate, and high submaximal exercise intensities respectively.   
The VO2 and RER values were averaged for the last 5 minutes (min 4 – min 9) of 
each submaximal exercise session and used to calculate carbohydrate and fat oxidation 
rates.  There were only two subjects, one from each group, who were unable to complete 
the full 9 minutes of submaximal exercise during the high intensity session.  For those 
subjects, only the minutes completed after minute 4 (i.e., steady-state obtained) were used 
in the calculations.  There was a significant (p ≤ 0.05) main effect of group and exercise 
intensity for both carbohydrate and fat oxidation rates (see Figure 1).  The treatment 
group oxidized significantly less carbohydrate and more fat across all exercise intensities 
when compared to the control group. 
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Figure 1 - Carbohydrate (CHO) and fat oxidation rates at different submaximal exercise 
intensities (mean ± SE).  Mod = Moderate intensity and Tx = Treatment grouping in the 
figure. 
 
There was a significant interaction effect of exercise intensity and time (i.e., pre 
vs. post) on blood lactate responses to the submaximal exercise sessions (p ≤ 0.05).  That 
is, the post-exercise lactate response became greater as exercise intensity increased in 
both groups.  There was also a signficant interaction effect for group and time within 
blood lactate responses (Figure 2).   Specifically, the latter finding points to there being a 
 43 
greater concentration of blood lactate in response to exercise (i.e., post) across all 
submaximal exercise sessions in the control group compared to the treatment group.   
* p < 0.05
0
1
2
3
4
5
6
7
Low Mod High
Intensity
B
lo
o
d
 l
a
ct
a
te
 (
m
m
o
l/
L
)
Treatment (Pre)
Treatment (Post)
Control (Pre)
Control (Post)
 
Figure 2 – Pre-exercise and post-exercise blood lactate values at different submaximal 
exercise intensities. Mod = Moderate intensity in figure.  
 
There was a significant (p ≤ 0.05) main effect of time on the blood glucose 
response across all submaximal exercise intensities (Figure 3); i.e., gluocse decreased 
post-exercise.  These blood glucose responses also approached significance (p = 0.079) 
for a three-way interaction of group, exercise intensity and time.  In this case, the control 
group tended to have lower resting gluocose and a more pronounced and consistent 
decrease in glucose concentrations post-exercise than the treatment group. 
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Figure 3 – Pre-exercise and post-exercise blood glucose values at different submaximal 
exercise intensities.  Mod = Moderate intensity in figure. 
  
Carbohydrate oxdiation and post-exercise blood lactate responses were 
significantly correlated (p ≤ 0.05) for both the treatment (r = 0.549) and control groups (r 
= 0.635).  Although there was a stronger correlation in the control group, it was not 
significantly different (p > 0.05) from the treatment group coefficient (Figure 4, 5). 
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Figure 4 – Carbohydrate oxidation rate and post-exercise blood lactate response at all 
submaximal exercise intensities in the treatment group. 
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Figure 5 – Carbohydrate oxidation rate and post-exercise blood lactate response at all 
submaximal exercise intensities in the control group.
  
 
CHAPTER V 
DISCUSSION 
Introduction 
The aim of this study was to develop a better understanding of substrate oxidation 
(i.e., energy metabolism) at different exercise intensities in post-treated breast cancer 
patients compared to healthy women.  The goal of obtaining this information is to 
provide insight into how to develop more accurate and precise exercise prescriptions for 
cancer patients. What follows is a discussion of the results and findings from this 
research study. This chapter contains a brief synopsis of the physiological outcomes, a 
comparison of the results with previous literature findings, and some possible 
physiological explanations as to why the results occurred.  Finally the practical 
implications of the findings are discussed. 
   
Exercise responses  
The subjects recruited into both study groups were predominantly sedentary in 
nature. This fact is confirmed by the predicted maximal oxygen uptakes in each group; 
treatment group = 22.0 ± 1.5 ml/kg/min, and control group = 24.1 ± 1.7 ml/kg/min.   
According to the American College of Sports Medicine these outcomes classify the 
groups at low levels of aerobic physical fitness (ACSM 2009).  
The subjects of each group responded appropriately to all submaximal exercise 
sessions (Brooks et al. 2005).  Specifically, there was a significant increase in VO2, RER, 
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HR, and RPE from rest to exercise during all submaximal exercise sessions in both 
groups.  Both groups also elicited significant and greater increases in VO2, RER, HR, and 
RPE during exercise as the intensity of the submaximal sessions increased from low 
(40% VO2max) to moderate (60% VO2max) to high (70% VO2max).   
Blood lactate levels also increased from rest to post-exercise and as the exercise 
sessions became more intense, there were larger increases in lactate.  An increase in 
blood lactate during exercise with greater increases in intensities agrees with previous 
studies (Brooks et al. 2005; Evans et al. 2009).  However, there was a significantly 
greater overall response in blood lactate to exercise in the control group compared to the 
cancer treatment group across all exercise intensities.  This finding agrees in part with the 
work of Evans and associates (Evans et al. 2009).  In that study the lactate responses of 
the cancer patients were only significantly less than that of healthy control subjects after 
high intensity exercise (~ 70% VO2max).   Why the results of the Evans and present 
studies are somewhat conflicting is uncertain.   These differences may be attributed to the 
mode of exercise (treadmill vs. cycle ergometer), the subject group characteristics, or the 
small sample sizes used in each of the studies.  Regardless of these differences, there is 
evidence in both studies for decreased blood lactate production during exercise in breast 
cancer patients when compared to healthy women.    
The present findings of overall lower lactate responses at all exercise intensities 
(low, moderate and high) in cancer patients is a new and novel finding. These lower 
lactate responses in the cancer group are in line with the reduced carbohydrate oxidation 
and greater fat oxidation found in this group compared to the control group across all 
exercise intensities. These physiological events are in agreement, that is, if less 
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carbohydrate is being oxidized, then a reduced amount of lactate should be produced 
(Brooks et al. 2005). It is well established that as exercise intensity increases there is a 
greater reliance on carbohydrate and a reduction in fat as an energy source, which was 
observed in both study groups (Brooks et al. 2005). But, the finding of between group 
differences in the magnitude of the oxidation rates of carbohydrate and fat is also a new 
novel finding, having never been reported in the literature previously.  It is unknown 
whether this reduced oxidation of carbohydrate in the cancer treatment group is resulting 
in the reduced lactate in the blood due to: substrate (i.e., glucose) being unavailable, a 
reduced glucose uptake by muscle, or a compromised glycolysis biochemical process in 
muscle. This last point cannot be determined from the present data, but is in need of 
evaluation within future studies. 
 
Possible physiological explanations 
Why carbohydrate oxidation is reduced and fat oxidation is enhanced in the 
cancer patients is unknown. Some of the possibilities may be related to pre-existing 
conditions, the actual disease process itself or the medical treatments administered to the 
patients.  The following discussion will explore some of these explanations and 
determine if they are plausible or not.   
While all of the women were considered healthy, (other than breast cancer in the 
treatment group), some women were also classified as overweight, obese or menopausal.   
Metabolic alterations have been displayed in overweight and obese populations which 
may increase lipolysis (McMurray & Hackney 2005).  During exercise, obese 
populations have blunted sympathetic nervous system and catecholamine response which 
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may alter the extent of lipolysis; however the rate of fat oxidation does not seem to differ 
between obese and normal weight individuals (McMurray & Hackney 2005).  Figure 1 
indicates, however, that there was a significant difference between groups in this study 
for fat oxidation.  Furthermore, there was no significant difference in BMI or body fat 
percentage between the groups (Table 3); therefore, the difference in substrate oxidation 
observed cannot be attributed to adiposity related factors.   
Women who have begun menopause begin to produce less estrogen from their 
ovaries which can impact metabolism (McMurray & Hackney 2005).  A lower level of 
circulating estrogen is associated with increased carbohydrate oxidation and blood lactate 
production during exercise; i.e., opposite of what was seen in the treatment group (Bunt 
1990; Evans et al. 2009; McMurray & Hackney 2005).  The results of this study show 
that there was no significant difference between groups for menopausal status; although 
there were actually more menopausal women in the treatment group than the control 
group.  Therefore a divergent menopausal status between the groups does not seem to 
explain the difference in fat and carbohydrate oxidation observed between the groups. 
The disease process of cancer has been associated with endocrine changes which 
may impact metabolism (Edmonson 1966; Glicksman & Rawson 1956; Marks & Bishop 
1956; Sommers 1955).   For example, a study by Sommers (1955) found that the majority 
of breast cancer patients presented with endocrine abnormalities; in particular, the 
pituitary and ovaries were found to be in a hyper-functional state.  It is believed that these 
abnormal endocrine gland actions cause an increase in estrogen release from either the 
ovaries or the adrenal cortex which is stimulated through the pituitary-adrenal pathway 
(Sommers 1955).  Increased circulating levels of estrogen can have large effects on 
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metabolism.  Specifically, estrogen can directly and indirectly increase lipolysis and lipid 
(fat) oxidation both at rest and during exercise (McMurray & Hackney 2005).    
The disease state of cancer has also been associated with mild to moderate 
hyperglycemia, glucose intolerance, and insulin resistance which may impact metabolism 
as well (Edmonson 1966; Glicksman & Rawson 1956; Marks & Bishop 1956).  There 
was no significant difference between groups for resting blood glucose in the current 
study which is consistent with some previous literature (Edmonson 1966; Glicksman & 
Rawson 1956).  However, resting levels of blood glucose were slightly higher in the 
cancer treatment group compared to the control group. Interestingly, there was less of a 
decrease in blood glucose after exercise in the cancer group when compared to the 
control group (Figure 2).  Although these glucose findings only approached significance 
(p < 0.10), they nonetheless support the concept of glucose intolerance in cancer 
populations which could be driven in-part by a developing insulin resistance (Edmonson 
1966; Glicksman & Rawson 1956; Marks & Bishop 1956).  Perhaps to some degree this 
effect is persisting even into exercise within the cancer patients and compromises their 
ability to metabolize carbohydrate. This however is only speculation and would need to 
be confirmed with an oral glucose tolerance test and hormonal measurements which was 
not possible in the current study. 
Specific cancer treatments may also be impacting metabolism in these breast 
cancer patients.  The goal of cancer treatments is to destroy cancerous tissues and cells 
(Lane & McKenzie 2005).  Radiation therapy is localized and destroys cancerous cells by 
fracturing their DNA sequence (Kaur et al. 2010).  Chemotherapy, anti-hormonal drug 
treatments such as Tamoxifen and Femara, and biological therapies such as Herceptin, 
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are all systematic therapies used to treat breast cancer (Kaur et al. 2010).  Although these 
treatments are meant to impact cancerous tissue primarily, they are not always selective 
and healthy systemic tissue may also be negatively impacted by these harsh treatments 
causing unwanted side effects (Lane & McKenzie 2005).  All of the cancer patients 
within this study had or were currently receiving some sort of systemic treatment (i.e., 
chemotherapy, anti-hormonal therapy, biological therapy).  It is highly possible that 
healthy cells are impacted when these systemic treatments target the cancer cells and 
destroy their metabolic process.  Decreasing carbohydrate metabolism ability within the 
cancer cell is essential to destroy the tumor but consequently it can be detrimental to 
healthy cells attempting to produce energy during exercise. 
Most of the patients (5 out of 7) in the current study were receiving anti-hormonal 
therapies such as Tamoxifen or drug agents which mimic Tamoxifen. While Tamoxifen, 
and similar drugs, are meant to work against the negative actions of estrogen at breast 
tissue, these drugs actually act in the same way as estrogen at many other tissues in the 
human body (NCI, 2010).  As stated earlier, increased amounts of circulating estrogen 
has both a direct and indirect effect on increasing lipid metabolism and inhibition of 
carbohydrate metabolism (Bunt 1990).  Although estrogen has direct effects on lipolysis 
it also may directly reduce glucose uptake in the muscle (McMurray &Hackney 2005).  
The current results support this concept through the observed decreased carbohydrate 
oxidation as well as less of a change in blood glucose in the cancer group during exercise.   
Exogenous estrogen can also have indirect effects on substrate oxidation.  Bunt 
(1990) has reported that estrogen can result in increased levels of cortisol, due to estrogen 
stimulating the adrenal cortex.  In addition, Tamoxifen has been shown to substantially 
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increase plasma cortisol concentrations in breast cancer patients (Levin et al. 1981). 
Cortisol is a powerful lipolytic hormone and is connected to increased fat metabolism at 
rest and during exercise (Hackney 2006).  The resulting lipolysis from cortisol elevations 
can be further enhanced through estrogen (or Tamoxifen acting like estrogen), by 
promoting growth hormone (hGH) release from the anterior pituitary (Bunt 1990). 
Growth hormone is likewise known to promote lipolysis and free fatty acid mobilization 
at rest and in response to exercise (Bunt 1990; Hackney 2006). Furthermore, these 
actions of cortisol and hGH can promote a reduction in glycogenolysis which in turn 
decreases glycolytic substrate availability and lactate production (Bunt 1990; McMurray 
& Hackney 2005).  
Additionally, estrogens have been shown to result in a chronic elevation of the 
insulin:glucagon (I:G) ratio which further reduces the rate of glycogenolysis (Bunt 1990). 
Such actions on the I:G ratio can lead to decreased insulin sensitivity, promote glucose 
intolerance and hyperglycemia (Bunt 1990; McMurray & Hackney 2005). Changes in 
glucose tolerance have been observed in women who receive exogenous estrogen through 
oral contraceptives or hormone replacement therapy (Bunt 1990).  Furthermore, women 
using oral contraceptives have exhibited higher blood glucose levels, greater hGH and 
cortisol responses, and slightly greater lipid oxidation and reduced glycogenolysis during 
submaximal exercise when compared to non-oral contraceptive users (Bunt 1990).   
Chemotherapy treatments and the use of Tamoxifen-like drugs may be 
compounding this myriad of events to further disrupt normal energy metabolism in 
cancer patients during exercise. This means that some drug therapies used by the cancer 
patients may result in part for their altered energy metabolism during exercise which 
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promotes the reduced lactate responses observed in this study. Obviously, without 
hormonal measurements from this study to confirm this hypothesis, the above must be 
considered speculation. Nonetheless, this does provide another and highly plausible 
explanation for the metabolic findings in the study. 
It is evident that there is decreased carbohydrate metabolism during exercise in 
post-treated breast cancer patients when compared to controls.  Whether this altered 
metabolism was evident before cancer was diagnosed or caused by the cancer and/or 
subsequent treatments is still unclear.  Further research needs to be conducted in this area 
to determine the exact cause of this phenomenon.  Regardless, the ultimate finding of 
decreased carbohydrate oxidation in breast cancer patients during exercise has significant 
practical implications for clinicians. 
 
Practical implications 
These results combined with the results from Evans et al. (2009) suggest that 
blood lactate levels taken post-exercise are not a good indicator of exercise intensity in 
breast cancer patients, especially at higher intensities (≥ 70% VO2max).  Furthermore, the 
ability to produce energy from carbohydrate metabolism during exercise is significantly 
diminished in breast cancer patients compared to healthy women.  Since glucose and 
glycogen (i.e., carbohydrate) are the predominant choices for energy production during 
high intensity exercise, this has implications for exercise prescription for this select group 
(McMurray & Hackney 2005).  Clinicians should understand that energy cannot be 
produced as rapidly through anaerobic glycolytic means in this population, making 
exercise at higher intensities more difficult.  Although there were no significant 
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differences in RPE between the groups at any intensity, current evidence supports that 
clinicians should still be conservative when working with breast cancer patients 
especially at higher exercise intensities.  Using a combination of heart rate and RPE may 
be a more effective and appropriate way to determine exercise intensity in exercising 
breast cancer patients (Evans et al. 2009).   
These are preliminary findings and more research needs to be performed before 
any specific exercise prescription guidelines can be created.   These findings can only be 
generalized to women who have been diagnosed with Stage I – III breast cancer and have 
finished all of their major medical treatments within the last 6 months.  Still, the results 
are striking and indicate that there is decreased carbohydrate oxidation and increased fat 
oxidation in breast cancer patient during exercise.  This information further supports the 
need for a conservative approach to individualized exercise prescription in this 
population as has been recommended by Battaglini et al. (2006). 
  
 
 
 
CHAPTER VI 
 
SUMMARY, CONCLUSIONS AND RECOMMENDATIONS 
Summary 
 Post-treated breast cancer patients and healthy women were matched for age, 
physical fitness level and menopausal status.  Each participant underwent a YMCA 
submaximal cycle ergometer test to predict their maximal oxygen consumption (VO2max).  
Based on the subjects VO2max, workloads were prescribed for submaximal exercise 
sessions at low (40% VO2max), moderate (60% VO2max) and high (70% VO2max) 
intensities.  Heart rate, rating of perceived exertion, oxygen uptake, and respiratory 
exchange ratio were continuously monitored throughout the exercise sessions.  Blood 
lactate and blood glucose were measured before exercise and 3 minutes into recovery.  
The breast cancer patients had a significantly (p ≤ 0.05) lower carbohydrate oxidation 
rate and higher fat oxidation rate at all exercise intensities compared to healthy women.  
The breast cancer patients also had a significantly (p ≤ 0.05) reduced blood lactate 
response to exercise at all submaximal exercise intensities compared to the healthy 
women.  The results support the concept that post-treated breast cancer patients have a 
greater capacity for lipid oxidation and a lessened capacity for carbohydrate oxidation 
during submaximal exercise.  This phenomenon results in decreased blood lactate 
production through glycolysis during exercise.  Although the exact mechanisms 
underlying these findings are unclear, the differences between groups may be attributed 
to the disease state of cancer and/or the subsequent cancer treatments.  Further research 
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needs to be done in this area to help elucidate the issue as to why this altered energy 
metabolism is occurring. 
 
Hypotheses (Accept or Reject) 
H1. No significant difference in lipid and carbohydrate oxidation will occur between the 
treatment and control groups during low (40% VO2max) and moderate (60% VO2max) 
exercise intensities.  (Reject) 
H2. Carbohydrate oxidation will be significantly lower and lipid oxidation will be 
significantly higher during exercise at high (70% VO2max) intensity in the treatment group 
when compared to controls. (Accept) 
H3. No significant difference in the blood lactate response will occur between the 
treatment and control groups during low (40% VO2max) and moderate (60% VO2max) 
exercise intensities. (Reject) 
H4. Blood lactate response will be significantly lower post-exercise at the high (70% 
VO2max) intensity in the cancer group when compared to controls. (Accept) 
H5. A significant correlation will exist between carbohydrate oxidation and blood lactate 
production in both healthy controls and cancer patients in response to exercise; however, 
this relationship will be significantly stronger in the healthy controls.  (Reject)  
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Recommendations for future studies 
Subjects 
A larger sample size and more homogeneous group of breast cancer patients 
would be recommended for future studies (i.e., same stage of cancer, type of treatment).  
Studying breast cancer patients who have had similar treatments may help to define if this 
altered metabolism during exercise is a product of certain treatments being administered.  
Lastly, exercise training has been shown to decrease estrogen levels but the synergistic 
effects tend to increase overall fat metabolism in healthy individuals (McMurray & 
Hackney 2005).  Therefore, it would also be interesting to see if similar changes in 
substrate oxidation occur in breast cancer patients after exercise training.   
Exercise sessions 
The YMCA submaximal cycle ergometer protocol to predict maximal oxygen 
uptake (VO2max) was used because it has been validated to be accurate in 20-54 year old 
healthy women (Beekley et al. 2004).  However, when working with some of the older 
subjects they had a difficult time with the first workload of 25 Watts (150 kgm/min).  
Therefore it is suggested that when working with a population over the age of 50 years 
old to begin the VO2max test at a lower workload.   If using an electric cycle ergometer, 
keeping the subjects at a pedal rate of 50 – 60 rotations per minute would also be 
recommended.  Subjects were told to pedal at a comfortable rate and there was a wide 
range of variability in pedal rate between individual subjects and this appeared to 
influence the subjects‟ perception of exercise difficulty.  
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Biochemical analysis 
Future studies should also investigate more physiological markers to determine 
why carbohydrate oxidation is reduced during exercise in breast cancer patients.  
Specifically, a more detailed dietary analysis along with an oral glucose tolerance test 
would be recommended.  This would help in-part to determine if energy metabolism was 
being altered through substrate availability or uptake at the muscle.  Furthermore, 
hormonal analysis of estrogen, cortisol, hGH, and insulin might give more information 
about how endocrine changes in breast cancer patients may impact substrate oxidation 
and energy metabolism during exercise. 
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Appendices 
A. Modified Physical Activity Questionnaire 
B. 24 Hour Recall for Food Intake 
C. Biochemical Analysis for Blood Lactate 
D. Biochemical Analysis for Blood Glucose 
E. Sample Calculations to Determine Substrate Oxidation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX A 
Physical Activity Questionnaire 
(Modeled after the Modifiable Activity Questionnaire) 
 
1. Over this past year, have you spent more than one week confined       
    to a bed or chair as a result of an injury, illness, or surgery?              Yes________  No_________ 
 If yes, how many weeks over this past year were you confined 
 to a bed or chair?                         _____________________________weeks 
 
2. Do you have difficulty doing any of the following activities? 
 a. Getting in or out of a bed or chair?          Yes________  No_________ 
 b. Walking across a small room without resting?         Yes________  No_________ 
 c. Walking for 10 minutes without resting?               Yes________  No_________ 
 
3. Please circle all activities listed below that you have done more than 10 times in the past year:
Jogging (outdoor, treadmill)………..1 
Swimming (laps, snorkeling).............2 
Bicycling (indoor, outdoor)…...........3 
Softball/Baseball……………............4 
Volleyball………………………......5 
Bowling…………………….............6 
Basketball………………………......7 
Skating (roller, ice, blading)……......8 
Martial Arts (karate, judo)….............9 
Tai Chi…………………….............10 
Calisthenics/Toning exercises……..11 
Wood chopping…………………....12 
Water/coal hauling…………….......13 
Football/Soccer…………………......14 
Raquetball/Handball/Squash…….....15 
Horseback riding……………….......16 
Hunting………………………….....17 
Fishing………………………….......18 
Aerobic Dance/Step Aerobic……....19 
Water Aerobics………………….....20 
Dancing (Square, Line, Ballrm)…....21 
Gardening or Yardwork……............22 
Badminton……………………….....23 
Strength/Weight training……...........24 
Rock climbing………………...........25 
Scuba Diving…………………….....26 
Stair Master…………………..........27 
Fencing………………………….....28 
Hiking………………………...........29 
Tennis……………………………...30 
Golf………………………………..31 
Canoeing/Rowing/Kayaking………32 
Water skiing…………………….....33 
Jumping rope………………………34 
Snow skiing (x-country/Nordic trk).35 
Snow skiing (downhill)……………36 
Snow shoeing……………………...37 
Yoga…………………………….....38 
Other…………………………….....39
Walking for exercise (outdoor, indoor at mall or fitness center, treadmill)……………………………………………………………………...................40
6
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 List each activity that you circled in the “Activity” box below, check the months you did each activity over the past year (12 months) and then estimate the 
average amount of time spent in that activity. 
Activity Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 
Average # of   
Times Per 
Month 
Average # of    
Minutes Each 
Time 
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4. In general, how many HOURS per DAY do you usually spend watching television? _____________________________ hours 
5. Did you ever compete in an individual or team sport (NOT including any time spent in sports during school physical education classes)? Yes_____  No_____ 
 If yes, how many total years did you participate in competitive sports?       _______________________________ years 
6. Have you had a job for more than one month over the past 12 months?           Yes________   No_________ 
List all JOBS that you have held over the past year for more than one month.  Account for all 12 months of the past year.  Please refer to the next page for job 
codes and categories.  If unemployed/disabled/retired/homemaker/student during all or part of the past year, list as such.  Think of your normal job activities of a 
normal 8 hour day, 5 day week 
Job Name Job Code 
Walk or 
bicycle 
to/from 
work 
AVERAGE JOB SCHEDULE 
Out of the total # of "Hrs/Day" reported working at 
this "job", how much of this time was usually spent 
sitting?  Enter this # in "Hrs Sitting" column, then 
place a check in the category which best describes 
their job activities when they were not sitting. 
Hrs spent sitting at work 
Check the 
category that 
best 
describes job 
activities 
when not 
sitting 
Min/Day Hrs/Day Day/Wk Mos/Yr Hrs sitting A B C 
                    
                    
                    
6
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Category A 
(Includes all sitting activities) 
 
Sitting 
Standing still w/o heavy lifting 
Light cleaning – ironing, 
cooking, washing, dusting 
Driving a bus, taxi, tractor 
Jewelry making/weaving 
General office work 
Occasional/short distance walking 
 
 
Category B 
(Includes most indoor activities) 
 
Carrying light loads 
Continuous walking 
Heavy cleaning – mopping, 
sweeping, scrubbing, vacuuming 
Gardening – planting/weeding 
Painting/Plastering 
Plumbing/Welding 
Electrical work 
 
 
Category C 
(Heavy industrial work, construction, farming) 
 
Carrying moderate to heavy loads 
Heavy construction 
Farming – hoeing, digging 
-  mowing, raking 
Digging ditches/shoveling 
Chopping/sawing wood 
Tree/pole climbing 
Water/coal/wood hauling 
 
 
JOB CODES 
Not employed outside of the home: 
1. Student 
2. Home Maker 
3. Retired 
4. Disabled 
5. Unemployed 
 
 
 
 
 
 
Employed (or volunteer): 
6. Armed Services 
7. Office worker 
8. Non-office Worker
6
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APPENDIX B 
The 24-hour Recall for Food Intake 
 
 The 24-hour recall consists of obtaining information on food and fluid intake for the previous 
day or previous 24 hours. 
 The 24-hour recall is based on the assumption that the intake described is typical of daily 
intake. 
 Although the 24-hour recall is one of the easiest methods for collecting information regarding 
the patient‟s intake, it is prone to error: 
 
1. Patient may not be able to recall the foods eaten. 
 It is often helpful to base questioning on the sequence of activities, beginning 
with questions such as, “What time did you get up in the morning?” and “What 
did you first eat?” and then proceed methodically in similar fashion through the 
next 24 hours. 
 Alternatively, try starting with the present and work back through the previous 24 
hours. 
 Patient may have a tendency to forget items like snack foods or sauces and 
gravies, but further probing of certain food items can jog the patient‟s memory on 
these and other points. 
2. Patient may not be able to estimate the amounts of each food eaten. 
 It may be helpful to have food models or illustrations of usual portion sizes 
available to provide a basis for comparison. 
3. Information given may not be sufficiently specific. 
 Use a checklist to provide greater accuracy of items listed by the patient. 
4. Patient may not be telling the truth. 
 Be careful to avoid suggesting the answers expected and try not to appear 
judgmental. 
5. Intake during the previous 24 hours may not be typical. 
 Patient should be asked about this, and if necessary should be further questioned 
about a more typical day‟s intake. 
 
Necessary components of the 24-hour recall: 
 Time the food or beverage was consumed 
 The food or beverage item  
 Serving size of the food or beverage item 
 How the food was prepared 
 Where the patient had the food or beverage item 
 Any relevant notes to the meal or food item 
 
Source: Zeman, F.J. and Ney, D.M. Applications in Medical Nutrition Therapy (1996). Prentice Hall: Upper Saddle River, 
NJ, pp. 53-54. 
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APPENDIX C 
Biochemical Analysis of Blood Lactate 
Methodology:  Electrochemical, Lactate Oxidase Biosensor 
Test Measured:  Blood Lactate 
Test Time:  13 seconds 
Test Strip Volume:  0.7 µL 
Battery Life (normal):  600 Tests 
Data Output Port:  Serial 
Electrochemical Biosensor:  Yes 
Calculates Average Results:  Yes 
Data Storage: Users/Tests:  10/130 
Data Transfer Port:  Yes 
Weight:  2.65 ounces (75g) 
Size:  3.6" x 2.3" x 0.9" (91.4mm x 58.4mm x 22.9mm) 
Measurement Range:  Lactate:  0.3 to 25.0 mmol/L 
Operating Ranges:  Temperature:  Lactate 41°F to 113°F (5°C to 45°C)           
          Altitude:  0 to 12,000 feet 
          Humidity:  10% to 90% relative humidity 
On-board Data Storage Files: 1 common file for 20 tests  
               9 additional files for 10 tests each  
               2 Quality Control files for 20 tests 
Typical Analytical Specifications for Imprecision: 
Within-Run Imprecision n=20,  
whichever is greater 
 Day-to-Day Imprecision n=20,  
whichever is greater 
 
Analyte  CV%  SD  CV%  SD 
Lactate  5.0  0.2 
(mmol/L) 
 7.0  0.3 
(mmol/L) 
 
Battery: Coin Type No. 2450 
Optional Accessories: Meter to PC data cable, with USB Port Adapter and PC data 
charting program (Windows® 2000 and beyond) 
Meter Warranty: Warranty effective for one year from purchase date. 
Certifications and Compliance: EMC (EN 55022 class B, IEC 801-2, EN 61000-4-3, 
ENV 50204, EN 61000-4-2) 
FOR PROFESSIONAL USE ONLY 
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APPENDIX D 
Biochemical Analysis of Blood Glucose 
Result Range: 20 to 600 mg/dL 
Calibration: Plasma-equivalent 
Sample: Fresh capillary whole blood 
Sample Size: Minimum 1 microliter 
Test Time: 5 seconds 
Assay Method: Glucose oxidase biosensor 
Power Source: One replaceable 3.0V (#2032 or equivalent) lithium battery 
Battery Life: About 1,000 tests (about one year at three tests per day) 
Glucose Units: mg/dL 
Memory: 150 blood glucose and control solution tests 
Automatic Shutoff: Two minutes after last user action 
Size: 3.12” x 2.25” x 0.85” 
Approximate Weight: 1.5 ounces with battery 
Operating Ranges: 
 Temperature 43 – 111 ºF/6 – 44 ºC 
 Relative Humidity 10 – 90% 
 Hematocrit 30 – 55% 
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APPENDIX E 
Sample Calculations to Determine Substrate Oxidation 
 
60% submaximal exercise session (example data only): 
 
Average VO2 over last 5 minutes:  1.059 L/min 
Average RER over last 5 minutes:  0.90 
 
RER chart at 0.90: 
- 4.924 kcal/L O2 
- 67.5 % from carbohydrate 
- 32.5% from fat 
 
4.924 kcal/L O2 x 1.059 L/min = 5.215 kcal/min 
 
Carbohydrate oxidation: 
5.215 kcal/min x 67.5% = 3.520 kcal/min 
1 g carbohydrate = 4.02 kcal 
(3.520 kcal/min) / (4.02 kcal/g) = 0.876 g/min 
 
Fat oxidation: 
5.215 kcal/min x 32.5% = 1.695 kcal/min 
1 g fat = 8.93 kcal 
(1.695 kcal/min) / (8.93 kcal/g) = 0.190 g/min
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